Tackling the root cause of treatment resistance in age-related macular degeneration
A novel strategy can potentially address a major challenge to the current treatment for CNV, the leading cause of irreversible blindness in the elderly.
Read MoreA novel strategy can potentially address a major challenge to the current treatment for CNV, the leading cause of irreversible blindness in the elderly.
Read More